Altamira Therapeutics Ltd. (NASDAQ:CYTO – Get Free Report) was the target of a large drop in short interest in the month of September. As of September 15th, there was short interest totalling 82,000 shares, a drop of 54.5% from the August 31st total of 180,200 shares. Approximately 2.2% of the company’s stock are short sold. Based on an average daily volume of 444,400 shares, the short-interest ratio is currently 0.2 days.
Altamira Therapeutics Stock Up 0.4 %
Altamira Therapeutics stock traded up $0.00 during mid-day trading on Thursday, reaching $0.67. 27,332 shares of the company were exchanged, compared to its average volume of 878,089. The business has a fifty day moving average of $0.95 and a 200 day moving average of $1.34. Altamira Therapeutics has a 12-month low of $0.67 and a 12-month high of $17.20.
About Altamira Therapeutics
See Also
- Five stocks we like better than Altamira Therapeutics
- The Significance of a Trillion-Dollar Market Cap Goes Beyond a Number
- Rocket Lab Stock Soars: Should Investors Chase the Rally?
- Financial Services Stocks Investing
- KB Home Slips After Earnings: What’s Next for Homebuilders?
- Comparing and Trading High PE Ratio Stocks
- Micron Stock Soars as AI Demand Fuels Big Q4 Earnings Beat
Receive News & Ratings for Altamira Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Altamira Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.